Arsenic trioxide: An anti cancer missile with multiple warheads

Yair Gazitt, Cagla Akay

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


The proven efficacy of ATO in the treatment of APL and the emerging importance of ATO in other diseases prompted extensive studies of the mechanisms of action of ATO in APL and in other types of cancers. In this review we will focus on downstream events in ATO-induced intrinsic and extrinsic apoptotic pathways with an emphasis on the role of pro-apoptotic and anti-apoptotic proteins and the role of p53 in ATO-induced apoptosis including its effect on cell cycle, its anti-mitotic effect and the role of apoptosis inducing factors (AIF) in ATO-induced apoptosis, chromatin condensation and nuclear fragmentation in myeloma cells as a model.

Original languageEnglish (US)
Pages (from-to)205-213
Number of pages9
Issue number3
StatePublished - Jun 2005


  • AIF
  • Apoptosis
  • Arsenic trioxide
  • BID
  • p53

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Arsenic trioxide: An anti cancer missile with multiple warheads'. Together they form a unique fingerprint.

Cite this